Letter: vaccination for global control of hepatitis B-from prevention to elimination. Authors' reply.
Autorzy:
HuiVW; Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Yip TC; Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Wong VW; Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Wong GL; Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.
Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
Autorzy:
Wong GL; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, China. HuiVW; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, China. Yip TC; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, China. Liang LY; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China. Zhang X; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China. Tse YK; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China. Lai JC; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, China. Chan HL; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Union Hospital; Hong Kong SAR, China. Wong VW; Medical Data Analytic Centre, The Chinese University of Hong Kong, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China.; Institute of Digestive Disease, The Chinese University of Hong Kong, China.
Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue-induced hepatitis B surface antigen loss.
Autorzy:
Yip TC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Medical Data Analytic Centre (MDAC), The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Wong VW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Medical Data Analytic Centre (MDAC), The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Tse YK; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Medical Data Analytic Centre (MDAC), The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Liang LY; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. HuiVW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Zhang X; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Li GL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Lui GC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Medical Data Analytic Centre (MDAC), The Chinese University of Hong Kong, Hong Kong SAR, China. Chan HL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Medical Data Analytic Centre (MDAC), The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Wong GL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Medical Data Analytic Centre (MDAC), The Chinese University of Hong Kong, Hong Kong SAR, China.; Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B.
Autorzy:
Yip TC; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Wong VW; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Chan HL; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Tse YK; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. HuiVW; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Liang LY; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Lee HW; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. Lui GC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Kong AP; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Wong GL; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2020 Sep; Vol. 27 (9), pp. 904-914. Date of Electronic Publication: 2020 May 14.
The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B.
Autorzy:
Wong GL; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Chan HL; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Yuen BW; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Tse YK; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Luk HW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Yip TC; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. HuiVW; Department of Statistics, The Chinese University of Hong Kong, Hong Kong SAR, China. Liang LY; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Lee HW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. Lui GC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. Wong VW; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
